Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug–Target Kinetics in Drug Discovery
Peter J. Tonge
ACS Chemical Neuroscience (2017) Vol. 9, Iss. 1, pp. 29-39
Open Access | Times Cited: 240

Showing 1-25 of 240 citing articles:

Why 90% of clinical drug development fails and how to improve it?
Duxin Sun, Wei Gao, Hongxiang Hu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3049-3062
Open Access | Times Cited: 859
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva, Craig M. Crews
Current Opinion in Chemical Biology (2019) Vol. 50, pp. 111-119
Open Access | Times Cited: 478
Challenges and Opportunities in Cancer Drug Resistance
Richard A. Ward, Stephen E. Fawell, Nicolas Floc’h, et al.
Chemical Reviews (2020) Vol. 121, Iss. 6, pp. 3297-3351
Closed Access | Times Cited: 329
Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis
Barbara Bosch, Michael A. DeJesus, Nicholas C. Poulton, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4579-4592.e24
Open Access | Times Cited: 237
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
Zhengnan Shen, Kiira Ratia, Laura Cooper, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2940-2955
Open Access | Times Cited: 176
Potential SARS-CoV-2 main protease inhibitors
Riddhidev Banerjee, L. Perera, L. M. Viranga Tillekeratne
Drug Discovery Today (2020) Vol. 26, Iss. 3, pp. 804-816
Open Access | Times Cited: 169
Ligand Gaussian Accelerated Molecular Dynamics (LiGaMD): Characterization of Ligand Binding Thermodynamics and Kinetics
Yinglong Miao, Apurba Bhattarai, Jinan Wang
Journal of Chemical Theory and Computation (2020) Vol. 16, Iss. 9, pp. 5526-5547
Open Access | Times Cited: 145
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 340-372
Open Access | Times Cited: 109
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
Triggered azobenzene-based prodrugs and drug delivery systems
Jundong Zhu, Tao Guo, Zheng Wang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 475-493
Closed Access | Times Cited: 85
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 56
Targeting G protein-coupled receptor signalling by blocking G proteins
Adrian P. Campbell, Alan V. Smrcka
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 11, pp. 789-803
Open Access | Times Cited: 154
Hit Generation in TB Drug Discovery: From Genome to Granuloma
Tianao Yuan, Nicole S. Sampson
Chemical Reviews (2018) Vol. 118, Iss. 4, pp. 1887-1916
Open Access | Times Cited: 96
Basic principles of drug delivery systems – the case of paclitaxel
S. Ezrahi, Abraham Aserin, Nissim Garti
Advances in Colloid and Interface Science (2018) Vol. 263, pp. 95-130
Closed Access | Times Cited: 91
Recent progress in molecular simulation methods for drug binding kinetics
Ariane Nunes‐Alves, Daria B. Kokh, Rebecca C. Wade
Current Opinion in Structural Biology (2020) Vol. 64, pp. 126-133
Open Access | Times Cited: 88
A workflow for exploring ligand dissociation from a macromolecule: Efficient random acceleration molecular dynamics simulation and interaction fingerprint analysis of ligand trajectories
Daria B. Kokh, Bernd Doser, Stefan Richter, et al.
The Journal of Chemical Physics (2020) Vol. 153, Iss. 12
Open Access | Times Cited: 82
TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations
Brion W. Murray, Dayong Zhai, Wei Deng, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 9, pp. 1499-1507
Open Access | Times Cited: 72
Advances in computational methods for ligand binding kinetics
Farzin Sohraby, Ariane Nunes‐Alves
Trends in Biochemical Sciences (2022) Vol. 48, Iss. 5, pp. 437-449
Closed Access | Times Cited: 38
Predicting Biomolecular Binding Kinetics: A Review
Jinan Wang, N. Hung, Kushal Koirala, et al.
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 8, pp. 2135-2148
Open Access | Times Cited: 37
Ligand Gaussian Accelerated Molecular Dynamics 2 (LiGaMD2): Improved Calculations of Ligand Binding Thermodynamics and Kinetics with Closed Protein Pocket
Jinan Wang, Yinglong Miao
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 3, pp. 733-745
Open Access | Times Cited: 25
Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137366-137366
Closed Access | Times Cited: 23
Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics
Stephan Eckert, Nicola Berner, Karl Kramer, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 11
Assessment of Antidiarrheal Effect of Oleuropein Through µ‐Oopioid Receptor Interaction Pathway: In Vivo and in Silico Studies
Nishat Jahan, Manoj Mandal, Imam Hossen Rakib, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access | Times Cited: 1
Drug–Target Association Kinetics in Drug Discovery
Adriaan P. IJzerman, Dong Guo
Trends in Biochemical Sciences (2019) Vol. 44, Iss. 10, pp. 861-871
Closed Access | Times Cited: 66
Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents
Behnoush Hajian, Eric W. Scocchera, Carolyn Shoen, et al.
Cell chemical biology (2019) Vol. 26, Iss. 6, pp. 781-791.e6
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top